{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:53Z","timestamp":1786118873987,"version":"build-2736575974"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/jcp.0b013e31814b98e5","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T03:02:59Z","timestamp":1189566179000},"page":"475-478","source":"Crossref","is-referenced-by-count":19,"title":["Influence of Topiramate on Olanzapine-Related Weight Gain in Women"],"prefix":"10.1097","volume":"27","author":[{"given":"Christoph","family":"Egger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Muehlbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.jcp.0000161501.65890.22","article-title":"Association between early and rapid weight gain and change in weight over one year of olanzapine therapy inpatients with schizophrenia and related disorders.","volume":"25","author":"Kinon","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.jcp.0000162800.64378.82","article-title":"The association of weight gain and olanzapine plasma concentrations.","volume":"25","author":"Perry","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl","key":"R3-10-20210128","first-page":"2735","article-title":"Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.","volume":"62","author":"Meltzer","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4088\/JCP.v65n1112","article-title":"Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.","volume":"65","author":"Nickel","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.jcp.0000162806.46453.38","article-title":"Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study.","volume":"25","author":"Nickel","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4088\/JCP.v63n1116a","article-title":"Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.","volume":"63","author":"Levy","year":"2002","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200710000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:59:19Z","timestamp":1786035559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200710000-00010"}},"subtitle":["An 18-Month Follow-Up Observation"],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31814b98e5","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}